The association between RBP4 and tumor size suggests that RBP4 may promote tumor growth, as also described in ovarian cancer, where RBP4 enhances migration and proliferation by activating RhoA/Rock1 and ERK pathways and upregulating MMP2 and MMP9 [17]. Here, MMP2 is linked to ovarian carcinoma.